Cover Image
Market Research Report
Product code 
1023307

Indiana Homecare Enteral Feeding Formula Market Size, Share & Trends Analysis Report By Product, By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow), By Stage, By Indication, And Segment Forecasts, 2021 - 2028

Published: | Grand View Research, Inc. | 92 Pages | Delivery time: 2-10 business days

Price

Back to Top
Indiana Homecare Enteral Feeding Formula Market Size, Share & Trends Analysis Report By Product, By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow), By Stage, By Indication, And Segment Forecasts, 2021 - 2028
Published: August 13, 2021
Grand View Research, Inc.
Content info: 92 Pages
Delivery time: 2-10 business days
  • ALL
  • Description
  • Table of Contents
Description

Indiana Homecare Enteral Feeding Formula Market Growth & Trends:

The Indiana homecare enteral feeding formula market size is expected to reach USD 127.9 million by 2028 and is expected to expand at a CAGR of 7.6% over the forecast period, according to a new report by Grand View Research, Inc. The rapidly growing global geriatric population is susceptible to chronic medical ailments such as diabetes, neurological disorders, cardiovascular diseases, stroke, and end-stage cardiac failure, which require clinical dietary management. As per the Indiana State Health Plan, the leading causes of death are CVD, diabetes, stroke, and cancer. According to Administration for Community Living in 2016, there were 49.2 million U.S citizens above the age of 65 years and, is expected to reach 82.3 million by 2040. It experienced an increase of 33% from 2006 to 2016. The rapidly aging society and pursual of an unhealthy lifestyle enhance the disease burden imposed by the geriatric population. The growing geriatric population, rising prevalence of chronic diseases, and product innovation in the homecare therapies segment are boosting market growth.

The growing rate of globalization, increasing pursual of unhealthy lifestyle habits, minimal physical activity, increased consumption of junk food and beverages, and tobacco and alcohol consumption if leading to the high global prevalence of chronic ailments and targeted diseases. Market players are constantly focusing on drug discovery and development to curate disease-specific formulas. Clinical nutrition is increasingly being used to personalize the treatment of chronic diseases such as cancer and cystic fibrosis. For instance, in the case of cystic fibrosis, special digestive enzyme capsules are administered. The nature of this digestive enzyme could vary in individuals. Established market players such as Nestle provide personalized clinical nutrition formulations such as Deplin for depression and Metanx for diabetes. As per studies, 70% of patients suffering from depression have a low ability to activate folate, and thus the need for specialized formulations, such as Deplin, is rising. Additionally, research activities in nutrigenomics, proteomics, and metabolomics to establish links between food and genes are rising and provides the impetus to the clinical nutrition market in personalized treatment regimens.

The development of gastrointestinal disorders, such as GI hypomotility in Covid-19 positive patients, contributed to the rise in demand for enteral feeding formulations. As per several studies, the use of enteral feed formulations for patients suffering from malnutrition due to contracting Covid-19 is justified. For instance, as per an article published in the Journal of the Academy of Nutrition and Dietetics, several patients admitted to the ICU for Covid-19 treatment suffer from acute malnourishment. Therefore, the use of clinical nutrition formulations is expected to increase in hospital and home care settings during the Covid-19 pandemic.

Indiana Homecare Enteral Feeding Formula Market Report Highlights:

  • The standard formula product segment dominated the market in 2020 due to the high usage of enteral nutrition for basic clinical nutritional needs and easy commercial availability
  • The intermittent feeding flow type segment dominated the market in 2020 due to the growing prevalence of neuromuscular disorders and allows greater patient mobility and physiological efficiency
  • The adults' segment dominated the market in 2020 owing to the increasing prevalence of malnourishment, impaired immunity, and poor muscle strength
  • The others indication segment dominated the market in 2020 owing to the growing prevalence of other chronic diseases such as COPD, cystic fibrosis, and other respiratory ailments
Table of Contents
Product Code: GVR-4-68039-492-8

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
  • 1.2 Market Definition
  • 1.3 Research Methodology
    • 1.3.1 Estimates And Forecast Timeline
    • 1.3.2 Methodology
    • 1.3.3 Analysis Of The Parents And Ancillary Markets
    • 1.3.4 Product Benchmarking
    • 1.3.5 Region, Country, State And Segment Level Market Size Estimates - Top Down
    • 1.3.6 Market Estimation And Forecast Factors
    • 1.3.7 Market Formulation & Data Validation
  • 1.4 Research Workflow
  • 1.5 Information Procurement
    • 1.5.1 Purchased Database
    • 1.5.2 Gvr's Internal Database
    • 1.5.3 Secondary Sources
    • 1.5.4 Third-Party Perspective
    • 1.5.5 Primary Research
  • 1.6 Information Analysis & Data Analysis Models
    • 1.6.1 Market Formulation & Validation
  • 1.7 Research Scope And Assumptions
  • 1.8 List To Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Product Outlook
  • 2.3 Competitive Insights
  • 2.4 Indiana Homecare Enteral Feeding Formulas Market Snapshot

Chapter 3 Indiana Homecare Enteral Feeding Formulas Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
      • 3.1.1.1 U.S. Nutritional Supplements Market
      • 3.1.1.2 U.S. Medical Foods Market
    • 3.1.2 Ancillary Market Outlook
      • 3.1.2.1 U.S. Parenteral Nutrition Market:
      • 3.1.2.2 U.S. Enteral Feeding Devices Market
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rising Geriatric Population
      • 3.3.1.2 Growing Prevalence Of Chronic Diseases
      • 3.3.1.3 Shifting Trend Towards Consumption Of Disease Specific Formulas
      • 3.3.1.4 Growing Demand For Neonatal And Preterm Enteral Feeding
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Lack Of Awareness Amongst The Medical Community
      • 3.3.2.2 Improper Categorization Of Clinical Nutrition
    • 3.3.3 Industry Challenges
      • 3.3.3.1 Complications Associated With Small-Bore Connectors
      • 3.3.3.2 Risks Associated With Enteral Feeding
    • 3.3.4 Industry Opportunity
  • 3.4 Indiana Homecare Enteral Feeding Formula Market Analysis Tools
    • 3.4.1 Industry Analysis: Porter's
      • 3.4.1.1 Bargaining Power Of Suppliers: Low
      • 3.4.1.2 Bargaining Power Of Buyers: Moderate
      • 3.4.1.3 Threat Of Substitution: Low
      • 3.4.1.4 Threat Of New Entrants: Moderate
      • 3.4.1.5 Competitive Rivalry: High
    • 3.4.2 Pestel Analysis
      • 3.4.2.1 Political And Legal Landscape
      • 3.4.2.2 Economic And Social Landscape
      • 3.4.2.3 Technology Landscape
  • 3.5 Major Deals & Strategic Alliances Analysis
    • 3.5.1 Mergers & Acquisitions
    • 3.5.2 Product Launches
    • 3.5.3 Funding And R&D Investment
    • 3.5.4 Product Recalls
  • 3.6 COVID-19 Impact on Indiana Homecare Enteral Feeding Formulas Market

Chapter 4 Indiana Homecare Enteral Feeding Formula Market: Product Estimates & Trend Analysis

  • 4.1 Market: Product Movement Analysis, 2020 & 2028, USD Million
  • 4.2 Standard Formula
    • 4.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
  • 4.3 Disease-specific Formula
    • 4.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 5 Indiana Homecare Enteral Feeding Formulas Market: Stage Estimates & Trend Analysis

  • 5.1 Market: Stage Movement Analysis, 2020 & 2028, (USD Million)
  • 5.2 Adult
    • 5.2.1 Market estimates and forecasts for adult, 2016 - 2028 (USD Million)
  • 5.3 Pediatric
    • 5.3.1 Market estimates and forecasts for pediatric, 2016 - 2028 (USD Million)

Chapter 6 Indiana Homecare Enteral Feeding Formulas Market: Flow-type Estimates & Trend Analysis

  • 6.1 Market: Flow-type Movement Analysis, 2020 & 2028, (USD Million)
  • 6.2 Continuous Feeding
    • 6.2.1 Market estimates and forecasts, 2016 - 2028 (USD Million)
  • 6.3 Intermittent feeding
    • 6.3.1 Market estimates and forecasts, 2016 - 2028 (USD Million)

Chapter 7 Indiana Homecare Enteral Feeding Formulas Market: Indication Estimates & Trend Analysis

  • 7.1 Market: Indication Movement Analysis, 2020 & 2028, (USD Million)
  • 7.2 Alzheimer's Disease
    • 7.2.1 Market estimates and forecasts for alzheimer's disease, 2016 - 2028 (USD Million)
  • 7.3 Nutrition Deficiency
    • 7.3.1 Market estimates and forecasts for nutrition deficiency, 2016 - 2028 (USD Million)
  • 7.4 Cancer Care
    • 7.4.1 Market estimates and forecasts for cancer care, 2016 - 2028 (USD Million)
  • 7.5 Diabetes
    • 7.5.1 Market estimates and forecasts for diabetes, 2016 - 2028 (USD Million)
  • 7.6 Chronic Kidney Diseases
    • 7.6.1 Market estimates and forecasts for chronic kidney diseases, 2016 - 2028 (USD Million)
  • 7.7 Orphan Diseases
    • 7.7.1 Market estimates and forecasts for orphan diseases, 2016 - 2028 (USD Million)
  • 7.8 Dysphagia
    • 7.8.1 Market estimates and forecasts for dysphagia, 2016 - 2028 (USD Million)
  • 7.9 Pain Management
    • 7.9.1 Market estimates and forecasts for pain management, 2016 - 2028 (USD Million)
  • 7.10 Malabsorption/GI Disorder/Diarrhea
    • 7.10.1 Market estimates and forecasts for malabsorption/GI disorder/diarrhea, 2016 - 2028 (USD Million)
  • 7.11 Others
    • 7.11.1 Market estimates and forecasts for others, 2016 - 2028 (USD Million)

Chapter 8 Indiana Homecare Enteral Feeding Formulas Market - Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
    • 8.2.1 Key Company Market Position Analysis, 2020
    • 8.2.2 List of Key Emerging Companies/Technology Disruptord/Innovators

Chapter 9 Competitive Landscape

  • 9.1 Company Profile
    • 9.1.1 MEAD JOHNSON & COMPANY, LLC
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial performance
      • 9.1.1.3 Product benchmarking
      • 9.1.1.4 Strategic initiatives
    • 9.1.2 BYRAM HEALTHCARE CENTERS, INC.
      • 9.1.2.1 Company overview
      • 9.1.2.2 Financial performance
      • 9.1.2.3 Product benchmarking
      • 9.1.2.4 Strategic initiatives
    • 9.1.3 REAL FOOD BLENDS
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial performance
      • 9.1.3.3 Product benchmarking
      • 9.1.3.4 Strategic initiatives
    • 9.1.4 SHIELD HEALTHCARE, INC.
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial performance
      • 9.1.4.3 Product benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 NUTRITIONAL MEDICINALS LLC
      • 9.1.5.1 Company overview
      • 9.1.5.2 Financial performance
      • 9.1.5.3 Product benchmarking
      • 9.1.5.4 Strategic initiatives
    • 9.1.6 KATE FARMS
      • 9.1.6.1 Company overview
      • 9.1.6.2 Financial performance
      • 9.1.6.3 Product benchmarking
      • 9.1.6.4 Strategic initiatives
    • 9.1.7 LIST OF OTHER COMPANIES

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Indiana homecare enteral feeding formula market, 2016 - 2028 (USD Million)
  • Table 4 Indiana homecare enteral feeding formula market, by product, 2016 - 2028 (USD Million)
  • Table 5 Indiana homecare enteral feeding formula market, by flow type, 2016 - 2028 (USD Million)
  • Table 6 Indiana homecare enteral feeding formula market, by stage, 2016 - 2028 (USD Million)
  • Table 7 Indiana homecare enteral feeding formula market, by indication, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Indiana homecare enteral feeding formula market segmentation
  • Fig. 2 Estimation Methodology
  • Fig. 3 Various stages of research workflow
  • Fig. 4 Information procurement
  • Fig. 5 Primary research pattern
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Indiana homecare enteral feeding formulas market summary, 2020, (USD Million)
  • Fig. 8 Indiana homecare enteral feeding formulas market trends & outlook
  • Fig. 9 Parent market analysis, 2020
  • Fig. 10 Timeline for new ENFit Connectors
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 Market driver analysis (Current & future impact)
  • Fig. 13 Increase in the number of people with chronic conditions in the U.S., 1995 - 2030 (in million)
  • Fig. 14 Market restraint analysis (Current & future impact)
  • Fig. 15 Indiana homecare enteral feeding formulas market, Product outlook: key takeaways, USD Million
  • Fig. 16 Indiana homecare enteral feeding formulas market: Product movement analysis, 2020 & 2028 (USD Million)
  • Fig. 17 Indiana standard formula market estimates and forecasts, 2016 - 2028 (USD Million)
  • Fig. 18 Indiana disease-specific formula market estimates and forecasts, 2016 - 2028 (USD Million)
  • Fig. 19 Indiana homecare enteral feeding formulas market, Stages outlook: key takeaways, USD Million
  • Fig. 20 Indiana homecare enteral feeding formulas market: Stages movement analysis, 2020 & 2028 (USD Million)
  • Fig. 21 Indiana homecare enteral feeding formulas market estimates and forecasts for adult, 2016 - 2028 (USD Million)
  • Fig. 22 Indiana homecare enteral feeding formulas market estimates and forecasts for pediatric, 2016 - 2028 (USD Million)
  • Fig. 23 Indiana homecare enteral feeding formulas market, Flow-type outlook: key takeaways, USD Million
  • Fig. 24 Indiana homecare enteral feeding formulas market: Flow-type movement analysis, 2020 & 2028 (USD Million)
  • Fig. 25 Indiana continuous feeding formula market estimates and forecasts, 2016 - 2028 (USD Million)
  • Fig. 26 Indiana intermittent feeding formula market estimates and Forecasts, 2016 - 2028 (USD Million)
  • Fig. 27 Indiana homecare enteral feeding formulas market: Indication outlook: key takeaways, USD Million
  • Fig. 28 Indiana homecare enteral feeding formulas market: Indication movement analysis, 2020 & 2028 (USD Million)
  • Fig. 29 Indiana homecare enteral feeding formula market estimates and forecasts for Alzheimer's disease, 2016 - 2028 (USD Million)
  • Fig. 30 Indiana homecare enteral feeding formula market estimates and forecasts for nutrition deficiency, 2016 - 2028 (USD Million)
  • Fig. 31 Indiana homecare enteral feeding formula market estimates and forecasts for cancer care, 2016 - 2028 (USD million)
  • Fig. 32 Indiana homecare enteral feeding formula market estimates and forecasts for diabetes, 2016 - 2028 (USD Million)
  • Fig. 33 Indiana homecare enteral feeding formula market estimates and forecasts for chronic kidney diseases, 2016 - 2028 (USD Million)
  • Fig. 34 Indiana homecare enteral feeding formula market estimates and forecasts for orphan diseases, 2016 - 2028 (USD Million)
  • Fig. 35 Indiana homecare enteral feeding formula market estimates and forecasts for dysphagia, 2016 - 2028 (USD Million)
  • Fig. 36 Indiana homecare enteral feeding formula market estimates and forecasts for pain management, 2016 - 2028 (USD Million)
  • Fig. 37 Indiana homecare enteral feeding formula market estimates and forecasts for malabsorption/GI disorder/diarrhea, 2016 - 2028 (USD Million)
  • Fig. 38 Indiana homecare enteral feeding formula market estimates and forecasts for others, 2016 - 2028 (USD Million)
  • Fig. 39 Heat map analysis, 2020